Bloomage BioTechnology Corporation Limited
SSE:688363.SS
48.84 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,370.77 | 6,075.924 | 6,359.192 | 4,947.774 | 2,632.734 | 1,885.571 | 1,263.146 | 818.049 | 733.123 | 650.868 | 481.301 | 375.18 | 274.966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1,392.562 | 1,621.028 | 1,463.227 | 1,085.252 | 489.47 | 383.569 | 253.582 | 200.592 | 165.973 | 173.186 | 105.904 | 75.321 | 84.317 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 3,978.209 | 4,454.896 | 4,895.965 | 3,862.521 | 2,143.264 | 1,502.002 | 1,009.564 | 617.457 | 567.15 | 477.682 | 375.397 | 299.859 | 190.649 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.741 | 0.733 | 0.77 | 0.781 | 0.814 | 0.797 | 0.799 | 0.755 | 0.774 | 0.734 | 0.78 | 0.799 | 0.693 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 466.25 | 446.347 | 388.188 | 284.338 | 141.158 | 93.886 | 52.866 | 25.719 | 23.963 | 29.803 | 15.655 | 15.153 | 9.713 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 181.892 | 138.957 | 127.848 | 97.075 | 38.894 | 42.623 | 54.224 | 175.049 | 110.075 | 141.91 | 104.128 | 116.109 | 44.099 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 1,829.014 | 2,842.387 | 3,049.367 | 2,436.175 | 1,099.272 | 521.368 | 283.746 | 125.475 | 107.004 | 107.07 | 74.646 | 58.618 | 33.154 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2,010.905 | 2,981.345 | 3,177.215 | 2,533.249 | 1,138.166 | 563.991 | 337.97 | 300.524 | 217.079 | 209.62 | 178.774 | 174.727 | 77.253 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 1,285.114 | 318.819 | 220.031 | 130.521 | 104.171 | 142.777 | -9.468 | -15.46 | 17.112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 3,762.269 | 3,746.51 | 3,785.434 | 2,948.109 | 1,383.496 | 800.654 | 518.003 | 333.346 | 256.158 | 239.423 | 173.787 | 168.327 | 73.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income
| 215.94 | 708.386 | 1,136.314 | 905.553 | 757.048 | 699.579 | 524.449 | 284.299 | 320.462 | 238.259 | 201.61 | 131.532 | 117.239 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio
| 0.04 | 0.117 | 0.179 | 0.183 | 0.288 | 0.371 | 0.415 | 0.348 | 0.437 | 0.366 | 0.419 | 0.351 | 0.426 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -2.547 | -6.663 | -0.202 | -15.354 | 1.85 | 1.76 | -9.468 | -0.235 | 9.456 | -0.359 | -2.494 | -5.375 | -5.458 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| 213.393 | 701.722 | 1,136.112 | 890.199 | 758.898 | 701.09 | 514.981 | 284.064 | 329.917 | 237.9 | 198.121 | 125.759 | 111.781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0.04 | 0.115 | 0.179 | 0.18 | 0.288 | 0.372 | 0.408 | 0.347 | 0.45 | 0.366 | 0.412 | 0.335 | 0.407 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 44.987 | 118.98 | 174.732 | 114.643 | 113.887 | 116.475 | 91.121 | 61.795 | 60.488 | 47.53 | 36.055 | 31.362 | 22.511 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| 174.267 | 592.556 | 970.919 | 782.335 | 645.839 | 585.608 | 423.86 | 222.269 | 269.429 | 190.393 | 162.067 | 94.398 | 89.272 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio
| 0.032 | 0.098 | 0.153 | 0.158 | 0.245 | 0.311 | 0.336 | 0.272 | 0.368 | 0.293 | 0.337 | 0.252 | 0.325 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.36 | 1.23 | 2.02 | 1.63 | 1.35 | 1.22 | 0.98 | 2.5 | 0.6 | 0.57 | 0.49 | 0.29 | 0.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS Diluted
| 0.36 | 1.23 | 2.02 | 1.62 | 1.35 | 1.22 | 0.97 | 2.5 | 0.6 | 0.55 | 0.47 | 0.28 | 0.28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA
| 522.569 | 1,007.328 | 1,382.179 | 1,063.712 | 840.4 | 766.334 | 564.035 | 331.102 | 365.524 | 287.194 | 215.721 | 144.294 | 122.165 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA Ratio
| 0.097 | 0.166 | 0.217 | 0.215 | 0.319 | 0.406 | 0.447 | 0.405 | 0.499 | 0.441 | 0.448 | 0.385 | 0.444 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |